Bone Biologics expects to complete clinical trial enrollment by year-end
Go back to Bone Biologics expects to complete clinical trial enrollment by year-end| (NASDAQ: BBLG) | Delayed: 0.72 -0.19 (20.88%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.91 | 52 Week High | $5.15 | |||
| Open | $0.67 | 52 Week Low | $1.99 | |||
| Day High | $0.73 | P/E | N/A | |||
| Day Low | $0.63 | EPS | $0.00 | |||
| Volume | 13,878,968 | |||||
| (NASDAQ: BBLGW) | Delayed: 5.97 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.97 | 52 Week High | $ | |||
| Open | $5.97 | 52 Week Low | $ | |||
| Day High | $5.97 | P/E | N/A | |||
| Day Low | $5.97 | EPS | $ | |||
| Volume | 4,808 | |||||
